Entera Bio Statistics
NASDAQ: ENTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.31+0.025 (+0.76%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Entera Bio by the numbers
Entera Bio has a market capitalization of $575.5 million based on 174.14M shares outstanding. With trailing EPS of $-0.40, Entera Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.8% above its 50-day average and 62.5% above its 200-day average.
Average daily trading volume is 438.35K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ENTX valuation vs. peer median
| Metric | ENTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $575.53M | $571.79M | +1% |
| Avg. volume | 438.35K | 637.10K | -31% |
Peer median across 8 companies: DBVT, FDMT, CGEM, SRZN, IAM, ETRA, VALN, DNA.
Valuation
- Market cap
- $575.53M
- Price / sales (latest FY)
- 13,702.99
- EPS (TTM)
- $-0.40
- Shares outstanding
- 174.14M
Price and trading
- Previous close
- 3.28
- Open
- 3.25
- Day range
- 3.18 – 3.32
- 52-week range
- 0.91 – 4.20
- 52-week change
- +30.63%
- Beta
- —
- Volume
- 468.44K
- Average volume
- 438.35K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 575.53M
- Forward Pe
- -6.01
- Eps
- -0.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.20
- Week52 Low
- 0.91
- Avg Volume
- 438.35K
- Shares Outstanding
- 174.14M
- Ma50
- 2.93
- Ma200
- 2.03
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -21.31%
- Pct From52w Low
- 263.19%